Investors and Media Relations
Infinity is an innovative drug discovery and development company seeking to discover, develop, and deliver to patients best-in-class medicines for difficult to treat diseases. Infinity combines proven scientific expertise with a passion for developing novel small molecule drugs that target emerging disease pathways. Infinity’s programs in the inhibition of the Hsp90 chaperone system, the Hedgehog pathway, fatty acid amide hydrolase and phosphoinositol-3-kinase (PI3-kinase) are evidence of its innovative approach to drug discovery and development.
Recent Releases
Sep 8, 2010
Infinity Pharmaceuticals to Present at Two Upcoming Conferences
Aug 4, 2010
Infinity Highlights R&D Progress and Announces Second Quarter 2010 Financial Results
more »
|
|
